Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06377267
Status:
RECRUITING
Last Update Posted:
2024-05-09
First Post:
2024-04-10
Brief Title:
Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab STROBE Trial
Sponsor:
Organization:
Vall dHebron Institute of Oncology